BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 2972167)

  • 1. Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis.
    Telimaa S; Puolakka J; Rönnberg L; Kauppila A
    Gynecol Endocrinol; 1987 Mar; 1(1):13-23. PubMed ID: 2972167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steroidal drugs in endometriosis.
    Kauppila AJ; Telimaa S; Rönnberg L
    Acta Obstet Gynecol Scand Suppl; 1989; 150():7-13. PubMed ID: 2533450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis after conservative surgery.
    Telimaa S; Rönnberg L; Kauppila A
    Gynecol Endocrinol; 1987 Dec; 1(4):363-71. PubMed ID: 2972171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variable effects of danazol on endometriosis at 4 low-dose levels.
    Dmowski WP; Kapetanakis E; Scommegna A
    Obstet Gynecol; 1982 Apr; 59(4):408-15. PubMed ID: 6210867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Danazol and medroxyprogesterone acetate inefficacious in the treatment of infertility in endometriosis.
    Telimaa S
    Fertil Steril; 1988 Dec; 50(6):872-5. PubMed ID: 2974428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of different treatment modalities of endometriosis in infertile women.
    Hull ME; Moghissi KS; Magyar DF; Hayes MF
    Fertil Steril; 1987 Jan; 47(1):40-4. PubMed ID: 2947817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of endometriosis with oral medroxyprogesterone acetate.
    Moghissi KS; Boyce CR
    Obstet Gynecol; 1976 Mar; 47(3):265-7. PubMed ID: 1250555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of pelvic endometriosis with low-dose danazol.
    Moore EE; Harger JH; Rock JA; Archer DF
    Fertil Steril; 1981 Jul; 36(1):15-9. PubMed ID: 6454591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of high-dose medroxyprogesterone acetate (HD-MPA) on hematological toxicity induced by chemotherapy for advanced solid tumors: a multicentric controlled clinical trial. MPA-Hematology Italian Cooperative Group.
    Chemioterapia; 1986 Apr; 5(2):134-9. PubMed ID: 2871945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The medroxyprogesterone acetate serum level following various medroxyprogesterone acetate dose schedules in gynecologic oncology].
    Husslein P; Egarter C; Eppel W; Salzer H; Spona J
    Zentralbl Gynakol; 1988; 110(20):1277-82. PubMed ID: 2977043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of oral medroxyprogesterone acetate in the treatment of endometriosis.
    Luciano AA; Turksoy RN; Carleo J
    Obstet Gynecol; 1988 Sep; 72(3 Pt 1):323-7. PubMed ID: 2970029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of intranasal buserelin acetate in the treatment of endometriosis: a review of six clinical trials and comparison with danazol.
    Trabant H; Widdra W; de Looze S
    Prog Clin Biol Res; 1990; 323():357-82. PubMed ID: 2106146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy of gestrinone and danazol in infertile women with endometriosis.
    Ruiz-Velasco V; Arceo JR; Armesto A
    Int J Fertil Menopausal Stud; 1993; 38(1):22-7. PubMed ID: 8485607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placebo-controlled comparison of hormonal and biochemical effects of danazol and high-dose medroxyprogesterone acetate.
    Telimaa S; Apter D; Reinilä M; Rönnberg L; Kauppila A
    Eur J Obstet Gynecol Reprod Biol; 1990; 36(1-2):97-105. PubMed ID: 2142109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leuprorelin acetate depot vs danazol in the treatment of endometriosis: results of an open multicentre trial.
    Crosignani PG; Gastaldi A; Lombardi PL; Montemagno U; Vignali M; Serra GB; Stella C
    Clin Ther; 1992; 14 Suppl A():29-36. PubMed ID: 1535020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical investigation of oral high-dose medroxyprogesterone acetate (MPA) in advanced breast cancer--double-blind controlled study: Japanese Group for MPA Treatment of Breast Cancer].
    Izuo M; Tominaga T; Yoshida M; Nomura Y; Abe O; Enomoto K; Kubo K; Takatani O
    Gan No Rinsho; 1985 May; 31(5):487-93. PubMed ID: 3160869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating lipid and lipoprotein concentrations during danazol and high-dose medroxyprogesterone acetate therapy of endometriosis.
    Telimaa S; Penttilä I; Puolakka J; Rönnberg L; Kauppila A
    Fertil Steril; 1989 Jul; 52(1):31-5. PubMed ID: 2526031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endometriosis and infertility. A review of sixty-two patients with danazol.
    Audebert AJ; Larrue-Charlus S; Emperaire JC
    Postgrad Med J; 1979; 55 Suppl 5():10-3. PubMed ID: 537947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosage aspects of danazol therapy in endometriosis: short-term and long-term effectiveness.
    Biberoglu KO; Behrman SJ
    Am J Obstet Gynecol; 1981 Mar; 139(6):645-54. PubMed ID: 6452062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of danazol treatment for minimal endometriosis in infertile women. A prospective, randomized study.
    Bayer SR; Seibel MM; Saffan DS; Berger MJ; Taymor ML
    J Reprod Med; 1988 Feb; 33(2):179-83. PubMed ID: 3351815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.